Hunan Er-kang Pharmaceutical (SHE:300267), through unit Er-Kang Tanzania Company, will invest $10 million to construct an integrated pharmaceutical formulation production facility in Tanzania, according to a Shenzhen bourse filing on Friday.
The construction will take 12 months, the Chinese pharmaceutical company said.